Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Larynx Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07441681
What this trial is testing

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+13 more
NRG Oncology 454
Not applicableStudy completedNCT00482872
What this trial is testing

Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt University Medical Center 400
Not applicableNot Yet RecruitingNCT06836765
What this trial is testing

The Relationship Between The Differential Expression Of FosB Protein In Laryngeal Cancer Tissues And Clinical Prognosis

Who this might be right for
Laryngeal Carcinoma
Yang ji 100
Testing effectiveness (Phase 2)Study completedNCT00720304
What this trial is testing

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 43
Not applicableStudy completedNCT01487733
What this trial is testing

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Who this might be right for
Head and Neck Cancer
Eastern Cooperative Oncology Group 155
Testing effectiveness (Phase 2)UnknownNCT00002454
What this trial is testing

Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx

Who this might be right for
Precancerous Condition
University of Medicine and Dentistry of New Jersey
Not applicableUnknownNCT04842994
What this trial is testing

Trial on Intraoperative Neuromonitoring (IONM) in Thyroid Cancer Surgery.

Who this might be right for
Malignant Neoplasm of Thyroid Gland
Tata Memorial Hospital 448
Not applicableEnded earlyNCT00591305
What this trial is testing

New Therapy of Laryngeal Papilloma In Children

Who this might be right for
Papilloma
Boston University 1
Early research (Phase 1)Ended earlyNCT00080028
What this trial is testing

Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerOropharynx CancerLarynx Cancer+1 more
Pharmacyclics LLC. 18
Large-scale testing (Phase 3)Study completedNCT00017511
What this trial is testing

Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerOral ComplicationsRadiation Toxicity
Daiichi Sankyo
Not applicableStudy completedNCT00765791
What this trial is testing

2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Alberta 40
Testing effectiveness (Phase 2)Study completedNCT03096808
What this trial is testing

Adaptive Radiotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerParanasal Sinus CancerOropharynx Cancer+4 more
Memorial Sloan Kettering Cancer Center 64
Large-scale testing (Phase 3)Ended earlyNCT00128817
What this trial is testing

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Who this might be right for
Larynx Neoplasms
Tata Memorial Hospital 900
Testing effectiveness (Phase 2)Study completedNCT00334997
What this trial is testing

Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis

Who this might be right for
Head and Neck Cancer
University College London Hospitals 50
Not applicableUnknownNCT03392220
What this trial is testing

A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic Laryngeal Cancer

Who this might be right for
Laryngeal NeoplasmsMalignant Neoplasm of Supraglottis PrimaryNeck Dislocation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 308
Testing effectiveness (Phase 2)Study completedNCT00003850
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 47
Large-scale testing (Phase 3)WithdrawnNCT01142414
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence

Who this might be right for
Head and Neck Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT00006033
What this trial is testing

Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Study completedNCT00021047
What this trial is testing

Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor

Who this might be right for
Esophageal CancerExtrahepatic Bile Duct CancerGastric Cancer+3 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)UnknownNCT03737968
What this trial is testing

Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients.

Who this might be right for
Stage II-IVB Operable HNSCC Oral CavityHypopharynxOropharynx+1 more
Yonsei University 48
Next Page